SMYD3 knockdown resulted in decreased mRNA levels of CCNA2, CCNB2, CCND2, CDK1, and CDK2, and increased mRNA levels of WEE1 [74], leading to S phase arrestin SMYD3-depleted ovarian cancer cells [73]. The gene discussed is SMYD3; the disease is ovarian carcinoma.